AAAAAA

   
Results: 1-2 |
Results: 2
Funding new cancer drugs in Ontario: Closing the loop in the practice guidelines development cycle
Authors: Pater, JL Browman, GP Brouwers, MC Nefsky, MF Evans, WK Cowan, DH
Citation: Jl. Pater et al., Funding new cancer drugs in Ontario: Closing the loop in the practice guidelines development cycle, J CL ONCOL, 19(14), 2001, pp. 3392-3396
Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-year results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk disease
Authors: MacKenzie, RG Franssen, E Wong, R Sawka, C Berinstein, N Cowan, DH Senn, J Poldre, P
Citation: Rg. Mackenzie et al., Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-year results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk disease, CL ONCOL-UK, 12(5), 2000, pp. 278-288
Risultati: 1-2 |